Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Routine CHN Microanalysis of Difficult Sample Types
Friday, September 12, 2014
CHN microanalysis methodologies for handling volatile liquids, air sensitive compounds and refractory materials.
Abzena Appoints Experts for Relocation to New Headquarters
Wednesday, September 10, 2014
Laboratory relocation specialist Andrew Porter Limited has completed the move of PolyTherics, a wholly owned subsidiary of Abzena, to the Babraham Research Campus in Cambridge.
RC900 Rotary Evaporator Wins Prestigious Red Dot Award
Thursday, September 04, 2014
An efficient, robust instrument set to transform rotary evaporation.
Selvita Licenses Cresset’s Forge and Spark
Thursday, September 04, 2014
Computational tools for SAR analysis and ligand-based design.
Optibrium Launches Sentira
: New Software for Compound Data Visualisation
Monday, August 11, 2014
Powerful desktop application simplifies visualisation, interpretation and presentation of compound data.
EasyFinder Online Selection Tool from Mettler Toledo
Friday, July 25, 2014
New tool helps customers find the perfect laboratory balances and scales with just a few clicks of their mouse.
Simultaneous Determination of Amlodipine and its Counterion Besylate
Friday, July 18, 2014
Determination of amlodipine and besylate by a simple, rapid, reliable, and accurate HPLC method.
Compact Sample Concentrator for R&D Departments
Tuesday, July 15, 2014
MiniVap™ blowdown sample concentrator from Porvair Sciences.
High Vacuum Benchtop Solvent Evaporator
Friday, July 11, 2014
The EZ-2 Elite Centrifugal Evaporator from Genevac.
Showing Results 51 - 60 of 1313
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,900+ scientific and medical posters
4,200+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!